Nisha Ohri

ORCID: 0000-0002-1310-4437
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Breast Cancer Treatment Studies
  • Breast Implant and Reconstruction
  • Breast Lesions and Carcinomas
  • Advances in Oncology and Radiotherapy
  • Advanced Radiotherapy Techniques
  • Occupational and environmental lung diseases
  • Brain Metastases and Treatment
  • Pleural and Pulmonary Diseases
  • Global Cancer Incidence and Screening
  • Cancer Treatment and Pharmacology
  • Lung Cancer Diagnosis and Treatment
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer Diagnosis and Treatment
  • Glioma Diagnosis and Treatment
  • Medical Imaging Techniques and Applications
  • Management of metastatic bone disease
  • Lung Cancer Treatments and Mutations
  • Economic and Financial Impacts of Cancer
  • Radiation Dose and Imaging
  • Lymphatic System and Diseases
  • Head and Neck Cancer Studies
  • Lung Cancer Research Studies
  • Endometrial and Cervical Cancer Treatments
  • Radiation Therapy and Dosimetry
  • Medical Imaging and Pathology Studies

Rutgers Cancer Institute of New Jersey
2017-2024

Rutgers, The State University of New Jersey
2017-2024

Johnson University
2024

Robert Wood Johnson University Hospital
2022

Columbia University Irving Medical Center
2020-2021

Herbert Irving Comprehensive Cancer Center
2020-2021

Georgetown University
2020

Georgetown University Medical Center
2020

Albert Einstein College of Medicine
2015-2019

Montefiore Medical Center
2015-2019

Treatment of oropharyngeal squamous cell carcinoma with chemoradiotherapy can now accomplish excellent locoregional disease control, but patient overall survival (OS) remains limited by development distant metastases (DM). We investigated the prognostic value staging <sup>18</sup>F-FDG PET/CT, beyond clinical risk factors, for predicting DM and OS in 176 patients after definitive chemoradiotherapy. <b>Methods:</b> The PET parameters maximum standardized uptake (SUVmax), metabolic tumor...

10.2967/jnumed.111.101402 article EN Journal of Nuclear Medicine 2012-08-14

The objectives of this study are to illustrate the effects immortal time bias (ITB) using an oncology outcomes database and quantify through simulations magnitude direction ITB when different analytical techniques used. A cohort 11 626 women who received neoadjuvant chemotherapy underwent mastectomy with pathologically positive lymph nodes were accrued from National Cancer Database (2004-2008). Standard Cox regression, time-dependent (TD), landmark models used compare overall survival in...

10.1177/1073274818789355 article EN cc-by-nc Cancer Control 2018-01-01

ACRIN 6668/RTOG 0235 evaluated the prognostic value of positron emission tomography with 18 F-fluorodeoxyglucose (FDG-PET) uptake before and after definitive, concurrent, platinum-based chemoradiotherapy for locally advanced non–small cell lung cancer (NSCLC). In this secondary analysis, we evaluate volumetric pretreatment PET measures as predictors clinical outcomes. Patients stage III NSCLC underwent FDG-PET prior to treatment. A commercially available gradient-based segmentation tool was...

10.1093/jnci/djv004 article EN JNCI Journal of the National Cancer Institute 2015-02-16

Malignant pleural mesothelioma (MPM) is a rare disease with very poor prognosis. Previous studies have indicated that women experience longer survival compared men. We analyzed 16 267 eligible patients (21.3% females) in the National Cancer Database to evaluate which clinical factors are independently predictive of survival. After adjusting for all covariates, was significantly better females males [HRadj: 0.81, 95% confidence interval (CI): 0.77-0.85]. Other associated were younger age at...

10.1093/carcin/bgz004 article EN Carcinogenesis 2019-01-04

Strong mentorship has been shown to improve mentee productivity, clinical skills, medical knowledge, and career preparation. We conducted a survey evaluate resident satisfaction with within their radiation oncology residency programs.

10.3389/fonc.2019.01369 article EN cc-by Frontiers in Oncology 2019-12-03
Elizabeth A. Hahn Stephanie L. Pugh Hien L. Lu Alyssa Vela Erin F. Gillespie and 95 more Elizabeth Nichols Jean L. Wright Shannon M. MacDonald Oren Cahlon Carole Baas Lior Z. Braunstein Lei Fang Gary M. Freedman Rachel Jimenez Christy Kesslering Mark V. Mishra Robert W. Mutter Nisha Ohri L Rosen James J. Urbanic Reshma Jagsi Sandra A. Mitchell Justin E. Bekelman David Cella Karen D. Godette Sagar P. Patel K Langen Ryan Zielan David DeBlois Dalong Pang Sonali Rudra S Benhabib Ashish Chawla Kuanling Chen Hossein Dadkhah Lonika Majithia Avani D. Rao Lisa Stephenson Peng Wang Victoria Croog Heng Li Karen Smith Susan Stinson Amanda J. Walker Kiran Devisetty Christian Hyde Nicholas Depauw Anuradha Godishala Alice Ho Harald Paganetti Daniel W. Soto Giselle Alexandra Suero-Abreu Alphonse G. Taghian Kimberly S. Corbin Michele Y. Halyard Amanda Jackson Xiaoying Liang Heather Manke L.A. McGee Deanna Pafundi Nicholas B. Remmes Dean A. Shumway Elizabeth Yan Samuel F. Bakhoum David Barron M. Bernstein John Cuaron Laura Dover D. Gelblum Philip Gilbo Richard M. Gewanter David Guttman Linda Hong Atif Khan Quincey LaPlant Justin L. Mann Beryl McCormick Boris Mueller Borys Mychalczak Dhwani Parikh Simon N. Powell Paul B. Romesser Diana Roth O’Brien Karen D. Schupak Annemarie F. Shepherd A.J. Xu Anthony Yu Melissa Zinovoy Jaafar Bennouna Marcio Fagundes Joseph Panoff Maria Amélia Rodrigues Jen Yu Choonsik Lee Chin‐Cheng Chen J. Isabelle Choi Haibo Lin Adil S. Akthar Nausheen Akhter Stephen A. Mihalcik

Our purpose was to evaluate the measurement properties of patient-reported outcome (PRO) measures used in ongoing RadComp pragmatic randomized clinical trial (PRCT).

10.1016/j.ijrobp.2024.03.020 article EN cc-by-nc International Journal of Radiation Oncology*Biology*Physics 2024-05-13

BACKGROUND High‐level evidence is lacking to guide treatment decisions about postmastectomy radiation therapy (PMRT) in patients who have breast cancer with 1 3 positive lymph nodes receive contemporary systemic therapies, leading potential variations PMRT delivery. The objective of this study was examine nationwide trends use group. METHODS National Cancer Data Base (NCDB) used identify 93,372 women had T1‐T2N1 diagnosed between 2003 and 2012. Patients received neoadjuvant chemotherapy or...

10.1002/cncr.31080 article EN Cancer 2017-11-07

Purpose Renal cell carcinoma (RCC) and melanoma have been considered 'radioresistant' due to the fact that they do not respond conventionally fractionated radiation therapy. Stereotactic radiosurgery (SRS) provides high-dose a defined target volume limited number of studies suggested potential effectiveness SRS in radioresistant histologies. We sought determine for treatment patients with brain metastases. Materials Methods performed retrospective review our institutional database identify...

10.3857/roj.2019.00409 article EN Radiation Oncology Journal 2019-12-31

Background Refugees and asylum-seekers have lower levels of cancer awareness this contributes to low rates screening more advanced cancers at diagnosis, compared non-refugee populations, due largely reduced access medical information care. The global Afghan refugee population is rapidly increasing with the ongoing political crisis. present study investigates breast (BC) among women.A cross-sectional survey women residing in Turkey was performed September 2021. A validated BC patient...

10.1016/j.eclinm.2022.101459 article EN cc-by-nc-nd EClinicalMedicine 2022-06-03

Abstract Background Access to cancer care is a problem that continues plague refugees displaced from their home countries. The turbulent political crisis in Syria, which has led millions of seeking asylum Turkey, merits further attention. We aimed study the rate utilization radiation therapy among Syrian with living Turkey an attempt identify contributing factors predictive non-compliance prescribed RT. Methods In this retrospective review 14 institutional databases, refugee patients...

10.1186/s12885-022-09558-5 article EN cc-by BMC Cancer 2022-05-12

Abstract Background Breast conserving surgery (BCS) and adjuvant hormonal therapy (HT) without radiation (RT) is an acceptable approach for older women with early stage, estrogen receptor (ER) positive breast cancer. Toxicity compliance remain issues HT. Adjuvant RT alone may have better compliance, but its efficacy in the absence of HT unclear. We aim to assess patterns survival outcomes among ER (ER+) Methods The National Cancer Data Base (NCDB) was used identify 130,194 age ≥65 years...

10.1002/cam4.3443 article EN cc-by Cancer Medicine 2020-09-17

Bisphosphonates such as zoledronic acid are an important part of adjuvant therapy to reduce the risk recurrence in early-stage breast cancer. Uveitis remains one lesser-known side effects acid; prompt recognition is essential ensure patients receive appropriate and timely care help prevent permanent vision loss. We report a case anterior uveitis postmenopausal woman who presented with visual symptoms after receiving first dose acid. This serves educate increase awareness given only reported...

10.1097/cad.0000000000001503 article EN Anti-Cancer Drugs 2023-02-24

Objective Gamma knife (GK) staged stereotactic radiosurgery (Staged-SRS) has become an effective treatment option for large brain metastases (BMs); however, it been challenging to evaluate the total dose because of tumor shrinkage between two sessions. This study aims biological (BED) in Staged-SRS, and compare BED with those single-fraction SRS (SF-SRS) hypo-fractionated (HF-SRS). Methods Patients treated GK Staged-SRS at a single institution were retrospectively included. The delivered...

10.3389/fonc.2022.892139 article EN cc-by Frontiers in Oncology 2022-06-30

Approximately 10% of patients who received brain stereotactic radiosurgery (SRS) develop symptomatic radiation necrosis (RN). We sought to determine the effectiveness treatment options for RN, based on patient-reported outcomes.

10.3857/roj.2020.00171 article EN Radiation Oncology Journal 2020-07-21
Coming Soon ...